Methyl 4-(pyridin-3-yl)benzoate

Catalog No.: 
ACWADS786
CAS No.: 
90395-47-4
Molecular Formula: 
C13H11NO2
Molecular Weight: 
213.24
Methyl 4-(pyridin-3-yl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$1635.001 week1 week

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-(pyridin-3-yl)benzoate
IUPAC Namemethyl 4-(pyridin-3-yl)benzoate
MDL No.MFCD00110082
Molecular FormulaC13H11NO2
Molecular Weight213.24
SMILESO=C(OC)C1=CC=C(C2=CC=CN=C2)C=C1
InChI KeySMXKPSLCRALELV-UHFFFAOYSA-N
SynonymMETHYL 4-(PYRIDIN-3-YL)BENZOATE;METHYL 4-(3-PYRIDINYL)BENZOATE;AKOS BAR-0407;Benzoic acid, 4-(3-pyridinyl)-, methyl ester
CAS No.90395-47-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWADS786 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDSAM359 route compound structure diagram
    ACDSAM359619-42-1In Stock
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACWADS786 route product structure diagram
    ACWADS78690395-47-4
Inquiry

2. ACWADS786 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACKCAM164 route compound structure diagram
    ACKCAM1644385-75-5In Stock
  4. Then
  5. ACWADS786 route product structure diagram
    ACWADS78690395-47-4
Inquiry

3. ACWADS786 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYCRV452 route compound structure diagram
    ACYCRV452619-44-3In Stock
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACWADS786 route product structure diagram
    ACWADS78690395-47-4
Inquiry

Comments (0)